The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N4-(5-ethyl-1H-pyrazol-3-yl)-5-fluoro-N2-phenethylquinazoline-2,4-diamine ID: ALA4876072
PubChem CID: 164627432
Max Phase: Preclinical
Molecular Formula: C21H21FN6
Molecular Weight: 376.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cc(Nc2nc(NCCc3ccccc3)nc3cccc(F)c23)n[nH]1
Standard InChI: InChI=1S/C21H21FN6/c1-2-15-13-18(28-27-15)25-20-19-16(22)9-6-10-17(19)24-21(26-20)23-12-11-14-7-4-3-5-8-14/h3-10,13H,2,11-12H2,1H3,(H3,23,24,25,26,27,28)
Standard InChI Key: SKFBRLBWFBITTM-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
22.7437 -12.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7525 -11.5609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0415 -11.1415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0280 -12.7944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3165 -12.3788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3234 -11.5520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6118 -11.1344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8930 -11.5426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8901 -12.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6022 -12.7864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0471 -10.3166 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7644 -9.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5124 -10.2525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0687 -9.6433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6610 -8.9259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8529 -9.0921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8885 -9.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3781 -9.0711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4544 -12.8072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1726 -12.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8834 -12.8200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6015 -12.4139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3100 -12.8361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0277 -12.4307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0356 -11.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3198 -11.1861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6050 -11.5939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6177 -10.3095 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 12 2 0
14 17 1 0
17 18 1 0
1 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
7 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.44Molecular Weight (Monoisotopic): 376.1812AlogP: 4.45#Rotatable Bonds: 7Polar Surface Area: 78.52Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.94CX Basic pKa: 5.24CX LogP: 5.39CX LogD: 5.38Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.44Np Likeness Score: -1.36
References 1. Uehling DE, Joseph B, Chung KC, Zhang AX, Ler S, Prakesch MA, Poda G, Grouleff J, Aman A, Kiyota T, Leung-Hagesteijn C, Konda JD, Marcellus R, Griffin C, Subramaniam R, Abibi A, Strathdee CA, Isaac MB, Al-Awar R, Tiedemann RE.. (2021) Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma., 64 (15.0): [PMID:34291633 ] [10.1021/acs.jmedchem.1c00506 ] 2. Tesmer, John J G JJ, Tesmer, Valerie M VM, Lodowski, David T DT, Steinhagen, Henning H and Huber, Jochen J. 2010-02-25 Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol. [PMID:20128603 ]